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OBJECTIVE: Distinct aspects can influence the complication rates of computed tomography-guided percutaneous
fine needle aspiration biopsy of lung lesions. The purpose of the current study is to determine the influence of
radiological techniques and clinical characteristics in predicting complications from this procedure.
SUBJECTS AND METHODS: A retrospective study was developed involving 340 patients who were submitted to a
consecutive series of 362 computed tomography-guided fine needle aspiration biopsies of lung lesions between July
1996 and June 2004, using 22-gauge needles (CHIBA). Variables such as the radiological characteristics of the lesions,
secondary pulmonary radiological findings, co-morbidities, and aspects concerning the procedure were studied.
RESULTS: The diameters of the lung lesions varied from 9 to 140 mm, with a mean of 51.5¡ 24.3 mm and median of
40 mm. The depth of the lesions varied from 10 mm to 130 mm, with a mean of 44¡ 20.9 mm, and median median
of 52 mm. Complications occurred in 52 (14.4%) cases, pneumothorax being the most frequent, with 40 (11.1%)
cases, followed by hemoptisis with 7 (1.9%) cases, and hematoma with 4 (1.1%) cases. Lesions that did not contact
the pleura, with normal pulmonary tissue interposition between lesion and pleura, had higher complication rates,
with 22 (22%) cases, than lesions that contact the pleura, with 6 (9%) cases, with a statistically significant difference
(p = 0.03).
CONCLUSIONS: CT-guided percutaneous fine needle aspiration biopsy of lung lesions had a lower rate of
complications in our study and presented more rates of complications on lesions that lack pleural contact.
KEYWORDS: Fine; Needle; Biopsy; Lung; Complication.
Guimara˜es MD, Andrade MQ, Fonte AC, Benevides G, Chojniak R, Gross JL. Predictive complication factors for ct-guided fine needle aspiration biopsy
of pulmonary lesions. Clinics. 2010;65(9):847-850.
Received for publication on May 4, 2010; Review completed on June 5, 2010; Accepted for publication on June 9, 2010
E-mail: marcos.guimaraes@accamargo.org.br
Tel.: 55 11 2189-5000 (1050)
INTRODUCTION
There is a significant variation in literature regarding the
potential for complications with computed tomography
(CT)-guided percutaneous fine needle aspiration biopsy
(FNAB) of thoracic lesions. The incidence of complications
ranges between 7% and 62%; pneumothorax is the most
frequent complication, and thoracic draining ranges
between 1% and 31%.1-5
Identifying characteristics such as the radiological aspects
of the lesions, secondary pulmonary radiological findings,
procedural aspects, and clinical characteristics such as co-
morbidities can help uncover the reason for complications
in patients submitted to the CT-guided FNAB of lung
lesions.6-7 The purpose of this study is to evaluate the
influence of these characteristics in predicting complications
from CT-guided FNAB of lung lesions.
SUBJECTS AND METHODS
This is a retrospective analysis of all consecutive patients
who received CT-guided FNAB of pulmonary lesions at an
oncological center in Brazil between 1996 and 2004. From a
total of 491 procedures evaluated, 362 (73.7%) were
considered eligible for this study. Of the 129 excluded
procedures, 6 (1.2%) were excluded because after cytologi-
cal evaluation or upon follow-up, the lesions were defined
as being on the chest wall or pleura; 26 (5.3%) were
excluded for having divergences between the admission
and chart registrations; and 97 (19.8%) were excluded
because the procedure was performed with cutting needles,
which are not the subject of this study. A total of 362
procedures performed on 340 patients are reported here; of
these 362 procedures, 319 were of lesions that were
submitted to biopsy once; 20 were of lesions submitted to
biopsy twice; and one was of a lesion submitted to biopsy
three times. Written informed consent was obtained from all
patients. Information was collected from the charts available
at the hospital’s Medical Archive Service (MAS) and the
percutaneous biopsy forms. These forms contain data
regarding the location, size, and number of the lesions, the
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distance between the lesion and the needle entrance site,
contour aspects of the lesions, and the relationship of
the contour aspects to adjacent structures such as the
mediastinum, or chest wall. Secondary radiological find-
ings such as atelectasis, pleural effusion, cavitations,
necrosis, infiltrates, adenopathy, and the presence of other
tumors and comorbidities were also included. Radiologic
findings were based on the CT report prior to the
procedure; the FNABs were conducted by an oncologic
radiologist with over 10 years experience in CT-guided
FNAB, or by a resident in radiology under his guidance,
following the standard procedure defined by the
Department of Radiology.8
At the Department of Radiology, coagulation tests were
checked routinely; when these tests were within normal
parameters, the biopsy was planned and performed using
a chest CT with thin slices (3–5 mm). The computer’s
cursor was used to measure the size of the lesions and the
distances of the lesions from the biopsy needle entrance
site. The skin was prepped with an antiseptic solution, and
local anesthesia, with 1% lidocaine, was applied. The
puncture needle was introduced, and new tomographic
cuts were obtained in order to confirm or modify the
needle position. The biopsies were performed within a
breath-hold.
The FNABs were performed using 22-gauge CHIBA-type
needles; subsequently, the obtained material was prepared
in smears and immersed in 90% alcohol. Due to the
retrospective nature of our study, it was not possible to
determine the number of thoracic transfixations done via
the FNAB procedure. However, the number of thoracic
transfixations was indirectly obtained using the number of
smears made by the puncture. In the experience of the
Department of Radiology at the Hospital of Cancer, each
puncture will supply approximately 4 smears.
Complications were considered when any new radiolo-
gical occurrence was presented at the control exams with
thoracic tomography being performed after biopsy, as well
as new clinical symptoms and signs such as shortness of
breath, intense dyspnea, thoracic pain, and hemoptisis
appearing after biopsy.
Control exams with 10 mm axial tomographic cuts
involving the entire thorax were performed immediately
and 2 to 4 hours after the procedure to confirm the presence
of complications such as pneumothorax and hematoma.
Pneumothorax was considered present when any material
with aerated density accumulated in the pleural space. The
tomographic control exam was anticipated if the patient
demonstrated any signs or symptoms of acute respiratory
discomfort. Hematoma was considered for each new
opacification that was related to the lesion and to the conti-
guous pulmonary normal tissue that appeared following the
puncture.
The presence of hemoptisis during and in the first
24 hours following the puncture was considered a compli-
cation as well.
By correlating the patient radiological data and co-
morbidities with complication occurrence, we were able to
determine the predictive factors for complication rates of
CT-guided FNAB of lung lesions. Descriptive statistics were
used when applied; the chi-square test or Fisher’s exact test
was applied when appropriate. A P value was considered
statistically significant when equal to or less than 0.05.
RESULTS
Of the 362 FNABs performed, 212 (58.6%) were per-
formed on male patients, and 150 (41.4%) were performed
on female patients. The mean age was 61 ¡ 16 years, and
the median age was 63 years old. The purpose of the FNAB
referral was to obtain a primary diagnosis of a suspected
malignant focal lesion in 215 (59.4%) procedures and to
document possible secondary malignancy in 147 (40.6%)
procedures.
The lung lesions were right-sided in 163 (45%) proce-
dures, and left-sided in 154 (42.5%) procedures. The lesion
distribution by pulmonary lobes was as follows: 76 (21.0%)
on the left superior lobe, 60 (16.6%) on the right superior
lobe, 58 (16.0%) on the right inferior lobe, 48 (13.3%) on the
left inferior lobe, and 27 (7.5%) on the middle lobe. In
addition, this information was not available in 93 cases
(25.7%).
The diameters of the lung lesions varied from 9 to 140 mm
(mean: 51.5 ¡ 24.3 mm; median: 40 mm); the distance
between the lesion and the biopsy entry point on the skin
varied from 10 to 130 mm (mean: 44 ¡ 20.9 mm; median:
52 mm). Additionally, 71 (40.1%) lesions were in contact with
the pleura, and 106 (59.9%) had pulmonary tissue between
the lesions and the pleura. The lesion contour type was
irregular in 96 patients (26.5%), spiculated in 38 patients
(10.5%), smooth in 37 patients (10.2%), and lobulated in 22
patients (6.0%); this information was not available in 169
cases (46.8%). In 148 (40.9%) procedures, the patient had one
lung lesion, and in 25 (6.9%) of the procedures, the patient
had two lesions. In 22 (6.1%) of the procedures, the patients
had three lesions, and in 43 (11.9%) of the procedures, four or
more lung lesions were present.
The most common secondary radiologic findings were
adenopathy (34 patients; 9.4%), additional tumors (32
patients; 8.8%), cavitation (16 patients; 4.4%), necrosis (14
patients; 3.9%), infiltration (13 patients; 3.3%), pleural
effusion (10 patients; 2.8%), and opacification on the present
lesion (4 patients; 1.1%).
From a total of 362 needle biopsies, a cytological result
was obtained from the patients’ charts for 357 (98.5%) of
those biopsies. Of the 357 punctures evaluated by the
pathologist, the material was considered adequate for
analysis in 304 biopsies (84%) and inadequate for analysis
in 53 biopsies (14.6 %). The frequency of material adequacy
for cytological analysis is shown in Table 1.
From a total of 362 biopsies, complications occurred in
51 (14.1%), pneumothorax being the most frequent. No
Table 1 - Cytological analysis results of 357 FNABs.
Material n (%)
Adequate for Analysis
Malignant 204 56.4
Suspicion of malignancy 38 10.5
Negative for malignancy 45 12.4
Possibly Benign 17 4.7
Total 304 84.0
Inadequate for Analysis
Insufficient 44 12.1
Inadequate 9 2.5
Total 53 14.6
No information 5 1.4
Total 362 100
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complications were reported in 281 (77.6%) cases, and there
was no available information in 30 (8.3%) cases, according to
Table 2.
There was no difference in the complication rates in
patients of different gender or age groups. There was also
no statistical difference in complication rates for biopsies
performed in groups of patients with different secondary
radiological lung findings.
Table 3 shows the distribution of the radiologic char-
acteristics of the lesions and the corresponding rates of
complications. The frequency of complications was higher
in lesions that lacked contact with the pleura and with
normal pulmonary tissue interposition between lesion and
pleura, than in the lesions that maintained contact with the
pleura (p = 0,03). There was no statistical difference in
complication rates with the others radiological character-
istics of lesions.
There was no difference in the complication rates of
patients belonging different co-morbidity groups. The
information of co-morbidity was presented in 96 patients,
as shown in Table 4.
Of the 51 (14.1%) patients who had complications, only 11
(21.1%) needed thoracic draining. Chronic obstructive
pulmonary disease (COPD) was the most common co
morbidity, with 5 (17.2%) cases of thoracic drainage. In
contrast, of the patients without COPD, 4 (5.8%) cases
demonstrated a statistically significant difference (p , 0.01).
The total number of smears was not predictive of compli-
cation rates.
DISCUSSION
Pneumothorax, pulmonary hematoma, and hemoptisis
are the most frequent complications of pulmonary biopsy
guided by imaging methods.4,6,7,10,11,14,16
The incidence of complications in CT-guided FNAB of
lung lesions depends on several factors. Radiological and
clinical characteristics such as size and depth of lesions,
advanced age, abnormal tests of pulmonary function, and
co-morbidities can contribute to the occurrence of complica-
tions.11-13
Austin and Cohen (1993) demonstrated that lesions that
contact the pleura do not develop into pneumothorax.16
Yankelevitz et al. (1997) demonstrated that the rate of
pneumothorax was 20%, and that only 5.3% needed
draining. They also observed that an increase in the
frequency of pneumothorax occurred in lesions that were
more than 30 mm away from the pleura, or nodules smaller
than 10 mm.5 Wallace et al. (2002) demonstrated the highest
rate of complications among the revised works, with CT-
guided FNAB of lung lesions smaller than 10 mm present-
ing pneumothorax in 62% of the cases and thoracic drainage
in 31% of the cases.5 One reason for this is that the multiple
needles tranfixations of the pleural space could be needed to
reach small and deep lesions when compared with super-
ficial and large lesions.
Li et al. (1996) had not demonstrated significant differ-
ences in the rates of complications of FNAB of lung lesions
Table 2 - Distribution of complications rates of CT-guided
FNAB of lung lesions.
Complications n (%)
Pneumothorax 40 11.1
Hemoptisis 07 1.9
Hematoma 04 1.1
No Complications 281 77.6
No Informations 30 8.3
Total 362 100
Table 3 - Analysis of lung lesions radiological
characteristics and occurrence of complications in CT-
guided FNAB of lung lesions.
Variables n (%)
n No
Complic (%)
n Yes
Complic (%) p
Contours 0.96
Smooth 37 (20.1) 5 (13.5) 32 (86.5)
Lobulated 22 (11.9) 3 (13.6) 19 (86.4)
Spikulated 34 (18.4) 4 (11.8) 30 (88.2)
Irreg n especif.*1 91 (99.6) 14 (15.4) 77 (84.6)
Width*2 0.11
#52mm 106 (48.8) 15 (14.2) 91 (85.8)
. 52mm 111 (51.2) 25 (22.5) 86 (77.5)
Lung 0.06
Right 153 (51.3) 26 (17.0) 127 (83.0)
Left 145 (48.7) 23 (15.9) 122 (84.2)
Size*3 0.79
,40mm 133 (49.9) 20 (15.0) 113 (85.0)
$40mm 134 (50.1) 24 (17.9) 110 (82.1)
Number of lesions 0.32
One 141 (62.3) 24 (17.0) 117 (83.0)
Two 24 (10.6) 5 (20.8) 19 (79.2)
Three 18 (7.9) 1 (5.6) 17 (94.4)
Four or more 43 (19.2) 4 (9.3) 39 (90.7)
Lobes 0.23
Superiors 130 (50.5) 19 (14.6) 111 (85.4)
Middle 27 (10.5) 2 (7.4) 25 (92.6)
Inferior 100 (39) 20 (20) 80 (80)
Pleura Contact 0.03
Yes 67 (40.1) 6 (9.0) 61 (91.0)
No 100 (59.9) 22 (22.0) 78 (78.0)
Vital Organs*4 0.27
Yes 30 (17.9) 3 (10) 27 (90)
No 137 (82.1) 25 (18.2) 112 (81.8)
*1 Irreg. non-specif., when contour of pulmonary injury was classified as
irregular by radiologist without other specifications.
*2 Superficial, when less or equal to the medium size; deep, when larger
than the medium size.
*3 Smaller Size, when less or equal to the medium size; larger size, when
larger than the medium size.
*4 Vital Organs, when there is a relation to structures considered as vital:
heart, main bronchi, heart, pulmonary hilum, trachea, pericardium,
inferior vena cava, aorta and pulmonary arteries and veins.
Table 4 - Complications rates according to co-morbidity
frequency.
Comorbity n (%)
COPD*1 30 8.3
Hypertension 29 8.0
Diabettes 18 5.0
IHD*2 05 1.4
CHF*3 04 1.2
Obesity 04 1.1
Others*4 06 1.6
*1 COPD - Chonic Obstructive Pulmonary Disease.
*2 IHD- Ischemic Heart Disease.
*3 CHF- Congestive Heart Failure.
*4 Others– Rheumatoid Arthritis, Lupus.
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with equal and smaller diameter than 15 mm versus FNAB
of lung lesions larger than 15 mm.[22] In the present work
there was no statistically significant difference in the ratio of
complications (p = 0,11) or the FNAB of superficial or deep
lesions, taking as reference the median (52 mm). However,
our study demonstrated more rates of complications on
lesions that lack contact with pleura, which could be
considered a landmark in differentiate that is superficial
from deep lesions.
Chojniak et al. (2006) demonstrated a rate of complication
in 16%, and thoracic draining in 4.9% of patients submitted
to CT-guided FNAB of lung lesions. 8 In our work, the rate
of pneumohorax was 11.1% and thoracic draining, 3.0%.
The Department of Radiology of Hospital AC Camargo is
a reference service and routinely performs CT-guided
FNAB.4,8,19 Perhaps the acquired experience, with proce-
dures over the past years, can minimize the occurrence of
complications in small and deep lesions of FNAB. However,
according the retrospective nature, this study could have
underestimated the rates of complications.
Yu’s et al. (2002) study on CT-guided percutaneous
biopsies with cutting needles presented a rate of 17.3%
complications, including: small pneumothorax with no
draining required (11.5%), hemoptisis (1.9%); pulmonary
hematoma (1.9%) and hematoma in the chest wall upon
needle trajectory (1.9%).4 Sulhatin et al. (2002) demonstrated
rates of 1.7% for hemoptisis and 1.4% for pulmonary
hematoma, also without significant clinical repercussions.11
Conces et al. (1987) reveal rates of pulmonary hematoma
and hemoptisis as 11% and 2%, respectively, with sponta-
neous resolution.16 In our study, the occurrence of compli-
cations such as hemoptisis and pulmonary hematoma was
1.9% and 1.1% respectively, with the same frequency found
in the literature. No cases of artery embolism and tumor
implantation were observed.
Pneumothorax occurrence increased following FNAB in
patients with COPD.13 Romano et al. (2004) found a
pneumothorax rate of 11.8% (27) in his study on CT-guided
FNAB lung lesions. Of these, only 6 (22.2%) required
thoracic draining, but they all suffered from COPD. 15
Vitulo et al. (1996) demonstrated that no parameter of
functional results were predictive for pneumothorax. The
only variables that correlated significantly with pneu-
mothorax in this study were the interposition of normal
tissue (p,0.01) and the depth of needle penetration in
pareˆnquima (p,0.05).12 On its own, COPD was not
predictive for pneumothorax in our study. This result could
have been influenced by the reduced amount of information
collected in relation to the expected amount for the co-
morbidities.
Kazerooni et al. (1996) demonstrated that there was a
higher rate of thoracic drainage in the population with
severe COPD.13 In our study, thoracic draining also
occurred with more frequency in patients with COPD, with
a statistically significant difference (p,0.01) in relation to
those without this co-morbidity. Although pulmonary
function has not been evaluated in the present study, these
patients usually have weak lung function and are suscep-
tible to more precocious and evident clinical manifestations,
even with a small pneumothorax, which makes them
require thoracic draining more frequently than those with-
out COPD.
CONCLUSION
CT-guided percutaneous FNAB of lung lesions had a
lower rate of complications in our study and presented
higher rates of complications on lesions that lack pleural
contact. COPD was the most common co-morbidity finding,
with higher rates of thoracic drainage. These radiological
and clinical characteristics should therefore be considered
when ordering this procedure.
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